It hides because of where it starts. The damage begins at the edges of vision, and the brain papers over the gaps for years. By the time you notice a chunk of the world missing, the optic-nerve fibres that mapped it are dead and don't grow back. So the hard part is detection: treatment is cheap and works, but it only protects what you still have.
Treatment is about as settled as medicine gets. Lowering eye pressure slows glaucomatous vision loss by roughly half, about 10% less progression risk per 1 mmHg dropped 1. In people with high pressure but healthy nerves, treating it halved the five-year odds of developing glaucoma 2. But nothing reverses damage already done.
Some people should start young. Prevalence runs about half a percent in your 40s and climbs toward seven percent by your late 70s 3. It's roughly four times as common in adults of African descent, with onset about a decade earlier 4. Glaucoma in the family, a thin cornea, or strong nearsightedness each raise your odds too 2. If two fit you, use the earlier schedule below.
Book a comprehensive dilated eye exam. It runs $50 to $200, is often covered by insurance, and takes under an hour. Ask for the optic-nerve look and an OCT scan, not just a pressure reading.
What the exam buys you. If you're clear, you leave with a clean baseline that makes the next scan easier to read. If something's caught, a daily drop or a one-time in-office laser holds it roughly in place for the decades of vision you'd otherwise lose. Skip it long enough and the loss runs one way: you stop driving at night, then stop driving, then miss a grandchild crossing the kitchen.
The fine print — when to skip it, and what people get wrong
A diagnosis only helps if you keep taking the drops. Even knowing they were electronically monitored, nearly half of patients used theirs under 75% of the time 6. Set an alarm and pair the drop with a daily habit.
- 1Heijl A, Leske MC, Bengtsson B, et al. (2002). Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology. link
- 2Kass MA, Heuer DK, Higginbotham EJ, et al. (2002). The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology. link
- 3Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. link
- 4Sommer A, Tielsch JM, Katz J, et al. (1991). Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Archives of Ophthalmology. link
- 5Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology. link
- 6Friedman DS, Quigley HA, Gelb L, et al. (2009). Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology. link
დაკავშირებული სახელმძღვანელოში (4)
- — The exam that catches glaucoma early is exactly this comprehensive check — eye pressure plus a careful look at the optic nerve.
- — Glaucoma is the other silent vision-stealer, but it hides where this grid won't show, so book the comprehensive exam.
- — The same dilated exam that screens for diabetic eye damage is where open-angle glaucoma usually gets caught too.
- — Glaucoma steals vision with no warning at all; sudden flashes, a curtain, or a grey patch are the opposite case — an emergency, not a slow creep.